SC
HRMY icon

Steven Cohen’s Harmony Biosciences HRMY Stock Holding History

Steven Cohen’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,778
Closed -$1.16M – 2484
2025
Q2 		$1.07M Buy
+33,778
New +$1.09M ﹤0.01% 1531
2021
Q4 		– Sell
-6,753
Closed -$259K – 1184
2021
Q3 		$259K Sell
6,753
-107,459
-94% -$3.46M ﹤0.01% 954
2021
Q2 		$3.22M Buy
+114,212
New +$3.43M 0.01% 681

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steven Cohen's HRMY Position: Q3 2025 in Review

Steven Cohen sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 33,778 shares — an estimated $1.16M sold.

Steven Cohen first reported a position in HRMY in Q2 2021 and held it in 3 quarters. The position peaked at $3.22M in Q2 2021. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Steven Cohen reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
  • Steven Cohen sold 33,778 Harmony Biosciences shares in Q3 2025, an estimated $1.16M.
  • Steven Cohen first reported a position in Harmony Biosciences in Q2 2021 and held it in 3 quarters.
  • Steven Cohen's Harmony Biosciences position peaked at $3.22M in Q2 2021.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.